Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions.
Celltrion Inc. said on April 8 that it has partnered with Canada’s iProgen Biotech Inc. to co-develop new antibody...








